PTEN, a tumor suppressor gene acting as a negative regulator of the PI3K/AKT/mTOR pathway, frequently undergoes copy number loss as an early event in prostate cancer development and its loss is correlated with progression to castration-resistant disease. Here, MTOR is linked to prostate carcinoma.